Alnylam Pharmaceuticals
ALNY
#622
Rank
HK$245.97 B
Marketcap
HK$1,907
Share price
2.75%
Change (1 day)
34.81%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Total assets

Total assets on the balance sheet as of September 2024 : HK$32.67 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company's total assets are HK$32.67 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alnylam Pharmaceuticals - Total assets on balance sheet (from 2003 to 2024)

Total assets by year

Year Total assets Change
2023-12-31HK$29.91 B7.95%
2022-12-31HK$27.70 B-2.47%
2021-12-31HK$28.40 B7.56%
2020-12-31HK$26.41 B41.59%
2019-12-31HK$18.65 B51.26%
2018-12-31HK$12.33 B-20.87%
2017-12-31HK$15.58 B59.15%
2016-12-31HK$9.79 B-8.88%
2015-12-31HK$10.74 B28.33%
2014-12-31HK$8.37 B156.79%
2013-12-31HK$3.26 B46.32%
2012-12-31HK$2.22 B1.78%
2011-12-31HK$2.18 B-28.45%
2010-12-31HK$3.06 B-18.01%
2009-12-31HK$3.73 B-12.92%
2008-12-31HK$4.28 B11.33%
2007-12-31HK$3.85 B106.26%
2006-12-31HK$1.86 B144.8%
2005-12-31HK$0.76 B48.43%
2004-12-31HK$0.51 B88.38%
2003-12-31HK$0.27 B117.05%
2002-12-31HK$0.12 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
HK$8.85 B-72.89%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$290.92 B 790.41%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.97 B-14.39%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$17.52 B-46.35%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.72 B-97.77%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$804.38 B 2,361.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$1.080 T 3,207.82%๐Ÿ‡ซ๐Ÿ‡ท France
HK$324.45 B 893.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel